IE801207L - Indole derivatives. - Google Patents

Indole derivatives.

Info

Publication number
IE801207L
IE801207L IE801207A IE120780A IE801207L IE 801207 L IE801207 L IE 801207L IE 801207 A IE801207 A IE 801207A IE 120780 A IE120780 A IE 120780A IE 801207 L IE801207 L IE 801207L
Authority
IE
Ireland
Prior art keywords
formula
carbon atoms
radical containing
compound
submitted
Prior art date
Application number
IE801207A
Other versions
IE49906B1 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IE801207L publication Critical patent/IE801207L/en
Publication of IE49906B1 publication Critical patent/IE49906B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

For the Contracting States : BE, CH, LI, DE, FR, GB, IT, LU, NL, SE 1. Compounds with the formula (I) : see diagramm : EP0021924,P23,F1 in which : - R represents a hydrogen atom, an alkyl radical containing from 1 to 8 carbon atoms or an aralkyl radical containing from 7 to 12 carbon atoms. - X represents a hydrogen atom or an alkyl radical containing from 1 to 8 carbon atoms, - Y represents a hydrogen atom or a halogen atom, - Z represents a hydrogen atom, an alkyl or hydroalkyl radical containing from 1 to 8 carbon atoms, an aryloxyalkyl radical containing from 7 to 12 carbon atoms, an aralkyl radical containing from 7 to 12 carbon atoms possibly substituted by one or more halogen atoms, by one or more alkoxy radicals containing from 1 to 4 carbon atoms, by one or more alkyl radicals containing from 1 to 4 carbon atoms, or by one or more radicals OH, CF3 , OCF3 , NO2 or NH2 or Z represents a cycloalkyl-alkyl radical containing from 4 to 12 carbon atoms, an alkenyl radical containing from 3 to 8 carbon atoms or an alkynyl radical containing from 3 to 8 carbon atoms and, - either a and b each represent a hydrogen atom, - or a represents a hydrogen atom and b represents a hydroxyl radical or an alkoxy radical containing from 1 to 8 carbon atoms, - or a and b together form a double carbon-carbon bond as well as the salts of addition with acids of the compounds with the formula (I). For the Contracting State : AT 1. Process for the preparation of compounds with the formula (I) : see diagramm : EP0021924,P25,F1 in which : - R represents a hydrogen atom, an alkyl radical containing from 1 to 8 carbon atoms or an aralkyl radical containing from 7 to 12 carbon atoms, - X represents a hydrogen atom or an alkyl radical containing from 1 to 8 carbon atoms, - Y represents a hydrogen atom or a halogen atom, - Z represents a hydrogen atom, an alkyl or hydroalkyl radical containing from 1 to 8 carbon atoms, an aryloxyalkyl radical containing from 7 to 12 carbon atoms, an aralkyl radical containing from 7 to 12 carbon atoms possibly substituted by one or more halogen atoms, by one or more alkoxy radicals containing from 1 to 4 carbon atoms, by one or more alkyl radicals containing from 1 to 4 carbon atoms, or by one or more radicals OH, CF3 , OCF3 , NO2 or NH2 or Z represents a cycloalkyl-alkyl radical containing from 4 to 12 carbon atoms, an alkenyl radical containing from 3 to 8 carbon atoms or an alkynyl radical containing from 3 to 8 carbon atoms and, - either a and b each represent a hydrogen atom, - or a represents a hydrogen atom and b represents a hydroxyl radical or an alkoxy radical containing from 1 to 8 carbon atoms, - or a and b together form a double carbon-carbon bond as well as the salts of addition with acids characterized in that a compound with the formula (I). see diagramm : EP0021924,P25,F2 in which X represents a hydrogen atom or an alkyl radical containing from 1 to 8 carbon atoms and Hal represents a halogen atom is submitted to the action of an alkylation or aralkylation agent, so as to obtain a compound with the formula (III) : see diagramm : EP0021924,P25,F3 in which R' represents an alkyl radical containing from 1 to 8 carbon atoms or an aralkyl radical containing from 7 to 12 carbon atoms, which is converted into an organo-magnesium derivative, so as to obtain a compound with the formula (IV) : see diagramm : EP0021924,P25,F4 which is condensed with N-benzyl 3-piperidone, so as to obtain a compound with the formula (IA ) : see diagramm : EP0021924,P26,F5 then, if desired - either the compound with the formula (IA ) is submitted to the action of a dehydratation agent, so as to obtain a compound with the formula (IB ) : see diagramm : EP0021924,P26,F6 which if desired, in the case where R' represents a benzyl radical is submitted to the action of a selective cleavage agent for the benzyl group carried by the nucleus of the indole, so as to obtain a compound with formula (IC ) : see diagramm : EP0021924,P26,F7 which, if desired, is submitted to the action of a cleavage agent for the benzyl group carried by the tetrahydropyridinyl nucleus, so as to obtain the compound of the formula (ID ) : see diagramm : EP0021924,P26,F8 - or the compound with the formula (IA ) is submitted to the action of a cleavage agent for the benzyl group carried by the nitrogen of the piperidinyl group, so as to obtain a compound with the formula (IE ) : see diagramm : EP0021924,P26,F9 which if desired is submitted to the action of a dehydratation agent, so as to obtain a compound with the formula (IF ) : see diagramm : EP0021924,P26,F10 - or, in the case where R' represents a benzyl group the compound with the formula (IA ) is submitted to the action of a selective cleavage agent for the benzyl group carried by the indole nucleus, so as to obtain a compound with the formula (IG ) : see diagramm : EP0021924,P26,F11 which, if desired, is submitted to the action of a cleavage agent for the benzyl group carried by the piperidinyl nucleus so as to obtain a compound with the formula (IH ) : see diagramm : EP0021924,P26,F12 then, if desired, each of the compounds obtained which respond to the formula (I) in which Z represents a hydrogen atom is submitted to the action of an agent able to introduce a radical Z', Z' having the same significante as Z, set out in claim 1, with the exception of hydrogen, so as to obtain the corresponding compounds with the formula (I) in which the nitrogen atom of the piperidinyl nucleus carries a radical Z' and, if desired, - either each of the compounds obtained responding to the formula (I) in which b represents a hydroxyl radical is submitted to the action of an etherification agent, so as to obtain the corresponding compounds with the formula (I) in which b represents an alkoxy radical containing from 1 to 8 carbon atoms, - or each of the compounds obtained responding to the formula (I) in which b represents a hydroxyl radical is submitted to the action of a dehydratation agent, so as to obtain the corresponding compounds with the formula (I) in which a and b together form a double carbon-carbon bond, - or each of the compounds obtained responding to the formula (I) in which b represents a hydroxyl radical, is submitted to the action of a cleavage agent for the hydroxyl group, so as to obtain the corresponding compounds with the formula (I) in which a and b each represent a hydrogen atom and, if desired each of the compounds with the formula (I) so obtained is submitted to the action of a halogenation agent able to introduce a halogen atom Hal in position 3 of the indole, so as to obtain the corresponding compound with the formula (I) in which Y represents a halogen atom, and if desired, each of the compounds with the formula (I) previously obtained is submitted to the action of an acid so as to form its salt.
IE1207/80A 1979-06-12 1980-06-11 New indole derivatives,process for preparing them,and pharmaceutical compositions containing them IE49906B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7914976A FR2458549A1 (en) 1979-06-12 1979-06-12 NOVEL INDOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS

Publications (2)

Publication Number Publication Date
IE801207L true IE801207L (en) 1980-12-12
IE49906B1 IE49906B1 (en) 1986-01-08

Family

ID=9226466

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1207/80A IE49906B1 (en) 1979-06-12 1980-06-11 New indole derivatives,process for preparing them,and pharmaceutical compositions containing them

Country Status (13)

Country Link
EP (1) EP0021924B1 (en)
JP (1) JPS5636480A (en)
AT (1) ATE2790T1 (en)
AU (1) AU533863B2 (en)
CA (1) CA1150265A (en)
DE (1) DE3062331D1 (en)
DK (1) DK186880A (en)
ES (1) ES492321A0 (en)
FR (1) FR2458549A1 (en)
HU (1) HU184785B (en)
IE (1) IE49906B1 (en)
PT (1) PT71372B (en)
ZA (1) ZA803217B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2486081A2 (en) * 1979-06-12 1982-01-08 Roussel Uclaf 4-Piperidinyl 1H-indole minus isomer - prepd. by resolving racemic mixt. with D minus tartaric acid
FR2492824A2 (en) * 1980-10-24 1982-04-30 Roussel Uclaf 4-Piperidinyl indole derivs. - with dopaminergic activity e.g. for treating Parkinsons disease and excessive prolactin secretion
FR2510111A1 (en) * 1981-07-24 1983-01-28 Roussel Uclaf NOVEL DERIVATIVES OF PIPERIDIN-3-YL INDOLE, THEIR SALTS, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
FR2510112A1 (en) * 1981-07-24 1983-01-28 Roussel Uclaf NOVEL DERIVATIVES OF 2-OXO-PYRID-3-YL OR PIPERIDIN-3-YL INDOLE, THEIR SALTS, PREPARATION METHOD, MEDICAMENT APPLICATION AND COMPOSITIONS COMPRISING THE SAME
FR2567884B1 (en) * 1984-07-19 1987-03-06 Roussel Uclaf NEW INDOLE DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
FR2578846B1 (en) * 1985-03-12 1987-05-22 Roussel Uclaf 7-HYDROXY INDOLE DERIVATIVES, THEIR SALTS, PREPARATION PROCESS, APPLICATION AS MEDICAMENTS, COMPOSITIONS CONTAINING AND INTERMEDIATES
FR2610929B1 (en) * 1987-02-13 1989-06-23 Roussel Uclaf BENZIMIDAZOL-2-ONE DERIVATIVES, SALTS THEREOF, PROCESS FOR PREPARATION, APPLICATION AS MEDICAMENTS, COMPOSITIONS CONTAINING AND INTERMEDIATES
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity
TW222631B (en) * 1991-07-15 1994-04-21 Duphar Int Res

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1030623A (en) * 1962-01-17 1966-05-25 Upjohn Co 3-substituted-indoles and their preparation
US3290332A (en) * 1965-08-30 1966-12-06 American Cyanamid Co 6, 7-dihydroindoles and derivatives thereof
US3501484A (en) * 1968-01-15 1970-03-17 Miles Lab Certain substituted 3 - (2-indolyl)-1,2,5,6-tetrahydropyridines and derivatives thereof
FR2391211A2 (en) * 1977-05-18 1978-12-15 Roussel Uclaf Antihypertensive 2-indolyl:piperidinyl-1-benzo-dioxanyl ethanol cpds. - which are prepd. from indolyl:piperidine cpd. and oxiranyl benzodioxan

Also Published As

Publication number Publication date
ATE2790T1 (en) 1983-04-15
HU184785B (en) 1984-10-29
JPH0113475B2 (en) 1989-03-06
AU533863B2 (en) 1983-12-15
EP0021924A3 (en) 1981-02-18
PT71372A (en) 1980-07-01
EP0021924B1 (en) 1983-03-16
IE49906B1 (en) 1986-01-08
ES8102119A1 (en) 1980-12-16
FR2458549A1 (en) 1981-01-02
DK186880A (en) 1980-12-13
PT71372B (en) 1981-10-21
ZA803217B (en) 1981-05-27
FR2458549B1 (en) 1981-10-16
DE3062331D1 (en) 1983-04-21
ES492321A0 (en) 1980-12-16
CA1150265A (en) 1983-07-19
AU5915380A (en) 1980-12-18
EP0021924A2 (en) 1981-01-07
JPS5636480A (en) 1981-04-09

Similar Documents

Publication Publication Date Title
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
ES8604546A1 (en) Phenylacetic-acid derivatives, medicines containing these compounds and process for their preparation.
FR2458549B1 (en)
PT81476B (en) PROCESS FOR THE PREPARATION OF QUINOLONO-CARBOXYLIC ACID DERIVATIVES
DK682288D0 (en) METHOD OF PREPARING QUINOLINCARBOXYL ACID
ES518666A0 (en) A PROCEDURE FOR THE PREPARATION OF AN ISOCROMAN.
ES2004809A6 (en) 1-[2-(Phenylmethyl)phenyl]-piperazine compounds, a process for preparing them and pharmaceutical compostions containing them.
GB2231570B (en) Naphthalenepropionic acid salts
ES342460A1 (en) Process for the production of piperazine derivatives
YU45607B (en) PROCEDURE FOR OBTAINING PYRIMIDINTRION DERIVATIVES
ES2157679T3 (en) PROCEDURE TO PREPARE A 2-CYANOBIFENYL COMPOUND.
NO852838L (en) PROCEDURE FOR N-DEMETHYLING OF MORPHINE ANALKALOIDS.
ES8403891A1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same.
DE68926016D1 (en) Halogeno-4-methylpyrazoles and process for their preparation
GB1001959A (en) New methoxy methyl chlorobenzoic acid and derivatives thereof and process for preparing same
NZ337031A (en) Process for preparation of vinyl sulfoxide compounds by using a benzyl sulfide
ES327758A1 (en) Procedure for the preparation of new derivatives of azepine. (Machine-translation by Google Translate, not legally binding)
GB901277A (en) Pyrrolidyl and piperidyl glycolates
ES8207535A1 (en) A procedure for the preparation of imidazodiacepine derivatives (Machine-translation by Google Translate, not legally binding)
GB821100A (en) Basically substituted 4-halogen-2-amino-1:3:5-trimethyl-benzenes and process for their manufacture